Statin-Induced Mitochondrial Coenzyme Q Deficiency Alters Mitochondrial Redox Homeostasis and Bioenergetic Function in Astrocytes
- 1Adam Mickiewicz University in Poznan
Abstract
Statins, widely used cholesterol-lowering drugs, inhibit the mevalonate pathway and reduce coenzyme Q (CoQ) biosynthesis, potentially impairing mitochondrial function. Because astrocytes are essential for maintaining brain redox homeostasis, statin-induced mitochondrial dysfunction in these cells may contribute to central nervous system pathology. Therefore, this study examined the effects of a 6-day statin exposure on mitochondrial bioenergetics in rat astrocytes, focusing on mitochondrial CoQ (mtCoQ) deficiency. Treatment with 200 nM atorvastatin or simvastatin decreased the total mtCoQ pool (mtCoQ9 + mtCoQ10) by 30%-35% and the antioxidant pool (mtCoQH2) by 40% but did not alter the levels of mitochondrial antioxidant proteins, including superoxide dismutase 2 and uncoupling proteins. Mitochondria of statin-treated astrocytes showed decreased respiratory activity, membrane potential, and ATP synthesis, and increased mtCoQ reduction leading to increased H2O2 production during the oxidation of complex I (CI) and CII substrates. Statin treatment also altered the organization of the respiratory chain, leading to downregulation of the CI+CIII2+CIV and CIII2+CIV supercomplexes and decreased protein levels and activity of all respiratory chain complexes. Moreover, decreased cytochrome a + a3 content was accompanied by reduced maximum CIV activity. CoQ10 supplementation elevated mtCoQ levels, restored mitochondrial respiratory function, and decreased both mitochondrial H2O2 production and mtQ reduction level in the respiring mitochondria of statin-treated astrocytes. Altogether, the results show that prolonged statin exposure alters mtCoQ redox homeostasis and impairs mitochondrial bioenergetic function in astrocytes. Notably, CoQ10 supplementation attenuates these changes, supporting its potential role in protecting astrocyte mitochondria from statin-induced dysfunction.
Related
- MASLD-Mitochondrial Digital Twin: Mapping mitonuclear epistasis to predict disease trajectory and systemic bioenergetic homeostasis
- A Combination of Ursolic Acid and Oleanolic Acid Disrupts Bioenergetic Homeostasis in Prostate Cancer and Inhibits Cancer Growth by Cytotoxic Autophagy
- Redox-dependent remodeling of mitochondrial nucleoids contributes to bioenergetic decline during neuronal aging
- Impaired mitochondrial proteostasis underlies cardiomyocyte bioenergetic dysfunction in a murine 3-hit model of heart failure with preserved ejection fraction
- Pantethine and Neurodegeneration: A Coenzyme A-Centered Framework Linking Metabolism, Neuroinflammation, and Mitochondrial Dysfunction
BibTeX
@misc{wojcicki2026statininduced,
title = {{Statin-Induced Mitochondrial Coenzyme Q Deficiency Alters Mitochondrial Redox Homeostasis and Bioenergetic Function in Astrocytes}},
author = {K. Wojcicki and L. Galganski and A. Budzinska and G. Figura and W. Pijanowski and W. Jarmuszkiewicz},
howpublished = {bioRxiv},
year = {2026},
month = jun,
doi = {10.64898/2026.06.10.731318},
url = {https://www.biorxiv.org/content/10.64898/2026.06.10.731318v2},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Statin-Induced Mitochondrial Coenzyme Q Deficiency Alters Mitochondrial Redox Homeostasis and Bioenergetic Function in Astrocytes
AU - K. Wojcicki
AU - L. Galganski
AU - A. Budzinska
AU - G. Figura
AU - W. Pijanowski
AU - W. Jarmuszkiewicz
PY - 2026
DA - 2026/06/10
PB - bioRxiv
DO - 10.64898/2026.06.10.731318
UR - https://www.biorxiv.org/content/10.64898/2026.06.10.731318v2
AB - Statins, widely used cholesterol-lowering drugs, inhibit the mevalonate pathway and reduce coenzyme Q (CoQ) biosynthesis, potentially impairing mitochondrial function. Because astrocytes are essential for maintaining brain redox homeostasis, statin-induced mitochondrial dysfunction in these cells may contribute to central nervous system pathology. Therefore, this study examined the effects of a 6-day statin exposure on mitochondrial bioenergetics in rat astrocytes, focusing on mitochondrial CoQ (mtCoQ) deficiency. Treatment with 200 nM atorvastatin or simvastatin decreased the total mtCoQ pool (mtCoQ9 + mtCoQ10) by 30%-35% and the antioxidant pool (mtCoQH2) by 40% but did not alter the levels of mitochondrial antioxidant proteins, including superoxide dismutase 2 and uncoupling proteins. Mitochondria of statin-treated astrocytes showed decreased respiratory activity, membrane potential, and ATP synthesis, and increased mtCoQ reduction leading to increased H2O2 production during the oxidation of complex I (CI) and CII substrates. Statin treatment also altered the organization of the respiratory chain, leading to downregulation of the CI+CIII2+CIV and CIII2+CIV supercomplexes and decreased protein levels and activity of all respiratory chain complexes. Moreover, decreased cytochrome a + a3 content was accompanied by reduced maximum CIV activity. CoQ10 supplementation elevated mtCoQ levels, restored mitochondrial respiratory function, and decreased both mitochondrial H2O2 production and mtQ reduction level in the respiring mitochondria of statin-treated astrocytes. Altogether, the results show that prolonged statin exposure alters mtCoQ redox homeostasis and impairs mitochondrial bioenergetic function in astrocytes. Notably, CoQ10 supplementation attenuates these changes, supporting its potential role in protecting astrocyte mitochondria from statin-induced dysfunction.
ER -